Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfer Factor Oral Solution for Atopic Dermatitis
ChiCTR2600124315Phase 4Recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dialyzable transfer factor in atopic dermatitis (AD) (2 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: EASI 75 at Day 42. Started May 2026; status: recruiting.
02
Drugs
dialyzable transfer factor
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2600124315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124315.